Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct

被引:35
作者
Maeshima, Akito
Vaughn, Duke A.
Choi, Yohan
Nigam, Sanjay K.
机构
[1] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
关键词
Wolffian duct; activin; ureteric bud outgrowth; Smad; BMP4; mesonephros; ectopic bud; nephrogenesis; autocrine;
D O I
10.1016/j.ydbio.2006.03.011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Development of metanephric kidney begins with ureteric bud outgrowth from the Wolffian duct (WD). GDNF is believed to be a crucial positive signal in the budding process, but the negative regulation of this process remains unclear. Here, we examined the role of activin A, a member of TGF-beta family, in bud formation using an in vitro WD culture system. When cultured with the surrounding mesonephros, WDs formed many ectopic buds in response to GDNF. While the activin signaling pathway is normally active along the non-budding WD (as measured by expression of activin A and phospho-Smad2/3), activin A was absent and phospho-Smad2/3 was undetectable in the ectopic buds induced by GDNF. To examine the role of activin A in bud formation, we attempted to inactivate activin action. Interestingly, the addition of neutralizing anti-activin A antibody potentiated GDNF action. To further clarify the role of activin A, we also tested the effect of activin blockade on the WD cultured in the absence of mesonephros. WDs without mesonephros did not form ectopie buds even in the presence of GDNF. In contrast, blockade of activin action with a variety of agents acting through different mechanisms (natural antagonist, neutralizing antibodies, siRNA) enabled GDNF to induce ectopic buds. Inhibition of GDNF-induced bud formation by activin A was accompanied by inhibition of cell proliferation, reduced expression of Pax-2, and decreased phosphorylation of PI3-kinase and MAP kinase in the WD. Our data suggest that activin A is an endogenous inhibitor of bud formation and that cancellation of activin A autocrine action may be critical for the initiation of this process. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:473 / 485
页数:13
相关论文
共 58 条
[1]   Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells [J].
Abe, Y ;
Abe, T ;
Aida, Y ;
Hara, Y ;
Maeda, K .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1302-1307
[2]   Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth [J].
Amthor, H ;
Christ, B ;
Rashid-Doubell, F ;
Kemp, CF ;
Lang, E ;
Patel, K .
DEVELOPMENTAL BIOLOGY, 2002, 243 (01) :115-127
[3]   Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction [J].
Basson, MA ;
Akbulut, S ;
Watson-Johnson, J ;
Simon, R ;
Carroll, TJ ;
Shakya, R ;
Gross, I ;
Martin, GR ;
Lufkin, T ;
McMahon, AP ;
Wilson, PD ;
Costantini, FD ;
Mason, IJ ;
Licht, JD .
DEVELOPMENTAL CELL, 2005, 8 (02) :229-239
[4]  
Brophy PD, 2001, DEVELOPMENT, V128, P4747
[5]   TGF-β superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud [J].
Bush, KT ;
Sakurai, H ;
Steer, DL ;
Leonard, MO ;
Sampogna, RV ;
Meyer, TN ;
Schwesinger, C ;
Qiao, JZ ;
Nigam, SK .
DEVELOPMENTAL BIOLOGY, 2004, 266 (02) :285-298
[6]   Studying TGF-β superfamily signaling by knockouts and knockins [J].
Chang, H ;
Lau, AL ;
Matzuk, MM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 180 (1-2) :39-46
[7]   Regulation of cell proliferation, apoptosis, and carcinogenesis by activin [J].
Chen, YG ;
Lui, HM ;
Lin, SL ;
Lee, JM ;
Ying, SY .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (02) :75-87
[8]   Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis [J].
Conery, AR ;
Cao, YN ;
Thompson, EA ;
Townsend, CM ;
Ko, TC ;
Luo, KX .
NATURE CELL BIOLOGY, 2004, 6 (04) :366-372
[9]   The transforming growth factor-β superfamily of receptors [J].
de Caestecker, M .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (01) :1-11
[10]  
Dressler GR, 1996, MED PEDIATR ONCOL, V27, P440, DOI 10.1002/(SICI)1096-911X(199611)27:5<440::AID-MPO9>3.0.CO